Angelle Desiree LaBeaud

Angelle Desiree LaBeaud

Auto-generated profile, based on publicly available information

Angelle Desiree LaBeaud

Affiliation Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CPChristopher J. Puntasecca
Christopher J. Puntasecca
CKCharles H. King
Charles H. King
ALAngelle Desiree LaBeaud
Angelle Desiree LaBeaud
Throughout the last decade, chikungunya virus (CHIKV) and Zika virus (ZIKV) infections have spread globally, causing a spectrum of disease that ranges from self-limited febrile illness to permanent severe disability, congenital anomalies, and early death. Nevertheless, estimates of their aggregate health impact are absent from the literature and are currently omitted from the Global Burden of Disease (GBD) reports. We systematically reviewed published literature and surveillance records to evaluate the global burden caused by CHIKV and ZIKV between 2010 and 2019, to calculate estimates of their disability-adjusted life year (DALY) impact. Extracted data on acute, chronic, and perinatal outcomes were used to create annualized DALY estimates, following techniques outlined in the GBD framework. This study is registered with PROSPERO (CRD42020192502). Of 7,877 studies identified, 916 were screened in detail, and 21 were selected for inclusion. Available data indicate that CHIKV and ZIKV caused the average yearly loss of over 106,000 and 44,000 DALYs, respectively, between 2010 and 2019. Both viruses caused substantially more burden in the Americas than in any other World Health Organization (WHO) region. This unequal distribution is likely due to a combination of limited active surveillance reporting in other regions and the lack of immunity that left the previously unexposed populations of the Americas susceptible to severe outbreaks during the last decade. Long-term rheumatic sequelae provided the largest DALY component for CHIKV, whereas congenital Zika syndrome (CZS) contributed most significantly for ZIKV. Acute symptoms and early mortality accounted for relatively less of the overall burden. Suboptimal reporting and inconsistent diagnostics limit precision when determining arbovirus incidence and frequency of complications. Despite these limitations, it is clear from our assessment that CHIKV and ZIKV represent a significant cause of morbidity that is not included in current disease burden reports. These results suggest that transmission-blocking strategies, including vector control and vaccine development, remain crucial priorities in reducing global disease burden through prevention of potentially devastating arboviral outbreaks.

23 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJamie Caldwell
Jamie Caldwell
ALA. Desiree LaBeaud
A. Desiree LaBeaud
ELEric F. Lambin
Eric F. Lambin
ASAnna Stewart
Anna Stewart
BNBryson A. Ndenga
Bryson A. Ndenga
EMErin A. Mordecai
Erin A. Mordecai
Climate drives population dynamics through multiple mechanisms, which can lead to seemingly context-dependent effects of climate on natural populations. For climate-sensitive diseases, such as dengue, chikungunya, and Zika, climate appears to have opposing effects in different contexts. Here we show that a model, parameterized with laboratory measured climate-driven mosquito physiology, captures three key epidemic characteristics across ecologically and culturally distinct settings in Ecuador and Kenya: the number, timing, and duration of outbreaks. The model generates a range of disease dynamics consistent with observed Aedes aegypti abundances and laboratory-confirmed arboviral incidence with variable accuracy (28–85% for vectors, 44–88% for incidence). The model predicted vector dynamics better in sites with a smaller proportion of young children in the population, lower mean temperature, and homes with piped water and made of cement. Models with limited calibration that robustly capture climate-virus relationships can help guide intervention efforts and climate change disease projections.

29 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NCNathaniel S. Chapman
Nathaniel S. Chapman
HZHaiyan Zhao
Haiyan Zhao
NKNurgun Kose
Nurgun Kose
JWJonna B. Westover
Jonna B. Westover
BKBirte Kalveram
Birte Kalveram
JCJames E. Crowe
James E. Crowe
Significance: Rift Valley fever virus (RVFV)–specific monoclonal antibodies from survivors of natural infection and vaccination were isolated to understand how RVFV is targeted for neutralization by the human immune system. These antibodies bind to specific regions of the viral surface, some of which are complex quaternary epitopes, and they block RVFV infection at extremely low concentrations. A new mechanism by which these mAbs can neutralize RVFV is described whereby the antibody may prevent necessary structural rearrangements in the viral proteins for infection. The antibodies isolated here have potential use in pre-exposure prophylaxis or post-exposure therapy against RVFV infection and should be studied further in that context.

7 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SNSindiso Nyathi
Sindiso Nyathi
IRIzabela M. Rezende
Izabela M. Rezende
KWKatharine S. Walter
Katharine S. Walter
PTPanpim Thongsripong
Panpim Thongsripong
FMFrancis M. M Mutuku
Francis M. M Mutuku
ALA. Desiree LaBeaud
A. Desiree LaBeaud
Despite the increasing burden of dengue, the regional emergence of the virus in Kenya has not been examined. This study investigates the genetic structure and regional spread of dengue virus-2 in Kenya. Viral RNA from acutely ill patients in Kenya was enriched and sequenced. Six new dengue-2 genomes were combined with 349 publicly available genomes and phylogenies used to infer gene flow between Kenya and other countries. Analyses indicate two dengue-2 Cosmopolitan genotype lineages circulating in Kenya, linked to recent outbreaks in coastal Kenya and Burkina Faso. Lineages circulating in Western, Southern, and Eastern Africa exhibiting similar evolutionary features are also reported. Phylogeography suggests importation of dengue-2 into Kenya from East and Southeast Asia and bidirectional geneflow. Additional lineages circulating in Africa are also imported from East and Southeast Asia. These findings underscore how intermittent importations from East and Southeast Asia drive dengue-2 circulation in Kenya and Africa more broadly.

19 November 2020 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
MFMe Foeller
Me Foeller
CNCameron Nosrat
Cameron Nosrat
AKAmy Krystosik
Amy Krystosik
TNTrevor Noel
Trevor Noel
PGPatrick Gérardin
Patrick Gérardin
MFMegan E Foeller
Megan E Foeller

20 April 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
AKAslam Khan
Aslam Khan
BNBryson Ndenga
Bryson Ndenga
FMFrancis M. M Mutuku
Francis M. M Mutuku
CBCarren Moraa Bosire
Carren Moraa Bosire
VOVictoria Okuta
Victoria Okuta
DLDesiree LaBeaud
Desiree LaBeaud
From 1975–2009, the WHO guidelines classified symptomatic dengue virus infections as dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. In 2009 the case definition was changed to a clinical classification after concern the original criteria was challenging to apply in resource-limited settings and not inclusive of a substantial proportion of severe dengue cases. Our goal was to examine how well the current WHO definition identified new dengue cases at our febrile surveillance sites in Kenya. Between 2014 and 2019 as part of a child cohort study of febrile illness in our four clinical study sites (Ukunda, Kisumu, Msambweni, Chulaimbo) we identified 369 dengue PCR positive symptomatic cases and characterized whether they met the 2009 revised WHO diagnostic criteria for dengue with and without warning signs and severe dengue. We found 62% of our PCR-confirmed dengue cases did not meet criteria per the guidelines. Our findings also correlate with our experience that dengue disease in children in Kenya is less severe as reported in other parts of the world. Although the 2009 clinical classification has recently been criticized for being overly inclusive and non-specific, our findings suggest the 2009 WHO dengue case definition may miss more than 50% of symptomatic infections in Kenya and may require further modification to include the African experience.